Drug-eluting stent restenosis treatment: an “old” stent, a “new” balloon or a “newer” scaffold?

The worldwide recurrent use of drug-eluting stent (DES), well explains that when the failure of this device occurs, namely in-stent restenosis (ISR), has great interest and impact on the daily clinical practice